-
India's power sector is expected to attract more than Rs 11 trillion in the next five years
Time of Update: 2022-12-28
electricity From April 2000 to June 2018, foreign direct investment (FDI) in the power sector cumulatively reached US$14.
electricity From April 2000 to June 2018, foreign direct investment (FDI) in the power sector cumulatively reached US$14.
-
The main force of Shanghai copper fluctuates upward, and the market fear of decline still exists
Time of Update: 2022-12-25
At the same time, the domestic port inventory of copper concentrate fell by 68,000 tons from the previous suppression, but remained at a high level of 915,000 tons, and the TC price only fell slightly by $0.
-
New revelation from TICOSPA research: axSpA standard treatment, is it a reality or a utopia
Time of Update: 2021-08-23
In addition, imaging results, patient comorbidities and other factors should be considered [3]; on the other hand, there is still a lack of There is no absolute consensus reference for target setting that can effectively prove that the efficacy of standard treatment is significantly better than that of conventional treatment .
-
CXO listing feast: after 4 arrows in a row, there are 7 more on the road
Time of Update: 2021-07-29
Basic situation of the four newly listed CXO companies Data source: prospectus Unit: 100 million yuan PE static (calculated based on 2020 net profit) Market value is based on the closing price at noon on June 28 From the above table, it has the following characteristics: 0 1 From the perspective of PE and market value, the capital market gives new high valuations .
-
Will atrial fibrillation increase the incidence of symptomatic intracranial hemorrhage after treatment in acute stroke patients? 丨ISC2021
Time of Update: 2021-04-28
The purpose of this study was to compare the incidence of symptomatic intracranial hemorrhage (sICH) in patients with and without a history of atrial fibrillation who received intravenous recombinant tissue plasminogen activator (IV rt-PA) and/or EVT.
-
Study on the evaluation of the efficacy of Chinese medicine to prevent recurrence of ischemic stroke stroke in China
Time of Update: 2020-07-07
at present, the of Chinese medicine in ischemic stroke in China is widely used in clinical treatment, but because of the lack of Chinese medicine in line with the international standards the eff
